SlideShare a Scribd company logo
1 of 20
PRESENTED BY:-
YASHICA JAIN(A008)
SHAGUN AGRAWAL(A001)
FINANCIAL ANALYSIS
OF NOVARTIS
PHARMACEUTICALS.
Discover, develop and successfully
market innovative products to
prevent and cure diseases, to ease
suffering and to enhance the quality
of life.
NOVARTIS
COMPANY PROFILE
and HISTORY
Novartis was created in 1996 through the merger of Ciba-
Geigy and Sandoz, two companies with a rich and diverse
corporate history. Headquartered in Basel, Switzerland
Novartis has been in India since 1947. The Group operates
in India through four entities namely Novartis India
Limited, Novartis Healthcare Private Limited, Sandoz
Private Limited and Chiron-Behring Vaccine Private
Limited.
In India Novartis have a presence in pharmaceuticals,
generics Vaccines, OTC (over-the-counter medicines), eye
care and Animal Health.
Novartis is among top 20 best performing companies
worldwide in carbon emissions from 2005 to 2012 out of
100 companies analyzed, Novartis ranked 18th across all
industries, 4th in the healthcare sector and 1st in
Switzerland.
Continued…
PRODUCT PROFILE
Novartis is the only company with leading
positions in each of these key areas:-
1) Pharmaceuticals: innovative patent-protected medicines
2) Alcon: global leader in eye care with surgical,
ophthalmology and consumer products
3) Sandoz: affordable, high-quality generic medicines and
biosimilars
4) Consumer Health: self-medication products and
treatments for animals
5) Vaccines and Diagnostics: vaccines and diagnostic tools
to protect against life-threatening diseases
SWOT Analysis
SWOT Analysis
Strength
1.Has a global reach in over 140 countries
2.Core businesses in pharmaceuticals, vaccines, consumer health,
generics and animal health
Weakness
1. Controversies regarding their advertising of certain products
affected brand image
Opportunity
1. Broad-based medical innovation, in technologies and
businesses across the spectrum of health care
2. Venture into health needs in under-developed and poor countries
Threats 1. Competition from peers
Financial and Ratio Analysis
Financial Analysis is the process of determining the operating &
financial characteristics of a firm from accounting data & financial
statement. The goal of such analysis is to determine efficiency &
performance of the firm management.
Financial analysis is undertaken to fulfil the following objectives.:-
such as,
 To estimate the earning capacity
 To know the financial position and financial performance of the
firm
 To determine the long terms liquidity of the funds as well as
solvency
 To decide about the future prospective of the firm
Financial Ratio analysis:-
 A ratio may be defined as a fixed relationship in
degree or number between two numbers.
 The ratio analysis is one of the most powerful tools
of financial analysis. It is use as a device to analysis
and interprets the financial health of enterprise.
 Ratio analysis is very helpful in financial
forecasting. Ratio relating to the past sales, profits
& financial position from the basis for setting
future trends.
Types of Financial Ratios:-
Liquidity Ratio
Current ratio Liquid ratio
Leverage Ratio
Debt equity Total Assets Proprietary Capital Interest
Ratio to Debt Ratio Gearing Coverage
Turnover Ratio
Stock Debtors Creditors Fixed assets working capital
Turnover turnover turnover turnover turnover
Profitability Ratio
Gross Operating Net profit
Profits Ratio Ratio
Profitability Ratio based on investment
Return on Return on Return on equity Earning Per
Capital Shareholder fund shareholder fund Share
Employed
Total Share Capital 15.98 15.98
Equity Share Capital 15.98 15.98
Share Application Money 0 0
Preference Share Capital 0 0
Reserves 801.89 687.01
Revaluation Reserves 0 0
Networth 817.87 702.99
Secured Loans 0 0
Unsecured Loans 0.14 0.2
Total Debt 0.14 0.2
Total Liabilities 818.01 703.19
Mar '12 Mar '11
12 mths 12 mths
Application Of Funds
Gross Block 23.37 24.15
Less: Accum. Depreciation 13.26 16.2
Net Block 10.11 7.95
Capital Work in Progress 0.1 0.73
Investments 0.03 0.04
Inventories 79.01 53.61
Sundry Debtors 69.95 60.38
Cash and Bank Balance 5.22 6.15
Total Current Assets 154.18 120.14
Loans and Advances 1,551.62 672.89
Fixed Deposits 80.06 82.31
Total CA, Loans & Advances 1,785.86 875.34
Deffered Credit 0 0
Current Liabilities 142.9 114.46
Provisions 835.19 66.43
Total CL & Provisions 978.09 180.89
Net Current Assets 807.77 694.45
Miscellaneous Expenses 0 0
Total Assets 818.01 703.17
Profit and Loss Account of Novartis india:-
31 march 2013 31 march 2012
Revenue:-
Revenue from Operations (Gross) 9,065.0 8,468.0
Less: Excise Duty 31.4 25.1
Revenue from Operations (Net) 9,033.6 8,442.9
Other Income 831.9 840.1
Total Revenue 9,865.5 9,283.0
Expenses:-
Cost of Materials Consumed 403.6 313.9
Purchases of Stock-in-Trade 3,579.3 3,023.8
Changes in Inventories of Finished
Goods and Stock-in-Trade (266.4) (222.9)
Employee Benefits Expense 1,623.0 1,376.8
Finance Costs 2.2 5.4
Depreciation Expense 35.9 26.7
Other Expenses 2,793.7 2,512.4
Total Expenses 8,171.3 7,036.1
Profit before Tax 1,694.2 2,246.9
Tax Expense
For the year
Current Tax 570.0 745.0
Deferred Tax 10.5 (15.0)
580.5 730.0
For earlier years
Current Tax (Net) (73.7) (3.3)
Fringe Benefits Tax (9.9) —
496.9 726.7
Profit for the year 1,197.3 1,520.2
Liquidity Ratio
Liquidity ratios are generally based on the relationship between current
assets and current liabilities . Liquidity ratio refers to the ability of the
firm to meet its short term obligations.
1.Current ratio:-
this is used to evaluate short term financial position of the business concern.
It compares the current assets and current liabilities of the firm.
Current ratio = current assets
Current liabilities
2012 2011
1785.86/978.09=1.9
i. e. 1.9:1
875.34/180.89=4.8
i.e. 4.8:1
Interpretation:-
Ideal current ratio should be
2:1. So, we can say that the
company’s financial position
is satisfactory in year 2011
and not satisfactory in year
2012
Liquid Ratio: -It is very useful in measuring liquidity position of a
firm. It measures the firm’s capacity to pay off current
obligations. It is used as complimentary ratio to the current ratio.
Quick ratio = liquid assets
Current liabilities.
2012 2011
1706.85/978.09=1.8
i. e. 1.8:1
821.73/180.89=4.5
i. e. 4.5:1
Interpretation:-
Liquid ratio of 1:1 is considered satisfactory. If quick assets are
equal to current liabilities, then the concern may be able to meet
its short term obligations. Here in both the years liquid asset is
greater than the current liabilities, hence the company is much
liquid in meeting its short term obligations during both the years.
Leverage ratios
Leverage ratios analyze the long term solvency that help us judge
the ability of a firm to pay the interest regularly
1.Debt equity ratio: shows a relationship between long term debt and
shareholder’s fund. This ratio indicates the relation between outsider’s
fund and shareholder’s fund. Also called external internal equity ratio
Debt equity ratio= debt or long term debt
Equity shareholder’s fund
.
2012 2011
0.14/817.87=0.00017 0.2/702.99=0.00028
Interpretation:-
A ratio of 1:1 is usually considered
to be satisfactory. This ratio is
calculated to know about the
organization’s repayment
capacity of long term debts.
Here the ratio obtained for both
the years is satisfactory.
2.Proprietary ratio: this establishes the relationship between
shareholder’s funds to assets of the firm. It is important for determining
long term solvency of the firm. Also known as equity ratio or net worth to
total assets ratio.
Proprietary ratio= Equity
Total assets
2012 2011
817.87/818.01=0.99 702.99/703.17=0.99
Interpretation:
Higher the ratio, dependency on external sources and loans for working
capital will be less and financial condition of the organization will be sound.
Here in both the years the ratio is same i. e. o.99 or 99% and very much
sound as it is much higher.
Turnover ratios
They indicate the rapidity with which the resources available to the
concern are being used to produce sales. In other words, they measure
the efficiency and rapidity of resources of the company
1. Stock turnover Ratio:- inventory ratio. This ratio indicates
relationship between cost of goods sold during the year and
average stock kept during that year.
Stock turnover ratio= cost of goods sold
Average stock
2012 2011
843.61/66.31=12.72 742.71/52.49=14.14
Interpretation:-
This ratio indicates whether stock
has been efficiently used or not
,the number of times the stock is
turned into sales during the year.
The higher the ratio, the better it
is, since it indicates that stock is
selling quickly. STR is much
higher in year 2011 compared to
2012, hence in 2011 the company's
stock has been turned into sales
efficiently.
2. Fixed assets turnover ratio: This ratio indicates relationship
between costs of goods sold and fixed assets during a year.
Fixed assets turnover ratio= cost of goods sold
Net fixed assets
.
2012 2011
845.61/154.18=5.47 742.71/120.14=6.18
Interpretation:-
This ratio reveals how efficiently the fixed assets are being utilized. If
there is increase in ratio, it indicates that there is better utilization of
fixed assets , here in year 2011 the fixed assets have been utilized
efficiently compared to year 2012.
3. Working capital turnover ratio: This ratio indicates relationship
between sales and working capital.
Working capital turnover ratio = cost of goods sold or sales
Working capital
2012 2011
845.61/807.77=1.04 742.71/694.45=1.06
Interpretation:-
This ratio reveals how efficiently working capital has been
utilized in making sales. A high working turnover ratio shows
efficient use of working capital. Here we find that working
capital of Novartis pharmaceuticals in year 2011 was efficiently
utilized to make sales.
CONCLUSION
After the overall financial ratio analysis of Novartis
pharmaceuticals , it is found that the financial
performance and management of company was sound
and efficient enough in year 2011 as compared to
2012,as the company was very much liquid during 2011 ,
current ratio was satisfactory , stock and working
capital was efficiently used.
THANK YOU

More Related Content

What's hot

GLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYGLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYDhanil Francil
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015Sabarinath Suryaprakash
 
Pfizer company analysis
Pfizer company analysisPfizer company analysis
Pfizer company analysisnero2.0
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisRahul Pagaria
 
Novartis AG: Science-Based Business
Novartis AG: Science-Based BusinessNovartis AG: Science-Based Business
Novartis AG: Science-Based BusinessKaran Jaidka
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryEngr. Carlo Senica, MBA, CPSM
 
Pfizer to Acquire Wyeth
Pfizer to Acquire WyethPfizer to Acquire Wyeth
Pfizer to Acquire Wyethfinance5
 
Novartis - Strategy Memo
Novartis - Strategy MemoNovartis - Strategy Memo
Novartis - Strategy MemoRheetam Mitra
 
Sun pharma acquires ranbaxy
Sun pharma acquires ranbaxySun pharma acquires ranbaxy
Sun pharma acquires ranbaxyMaster Verma
 
Presentation on cipla project
Presentation on cipla projectPresentation on cipla project
Presentation on cipla projectPratyush Mishra
 

What's hot (20)

Cipla final
Cipla finalCipla final
Cipla final
 
GLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRYGLOBAL PHARMACEUTICAL INDUSTRY
GLOBAL PHARMACEUTICAL INDUSTRY
 
mba 599- pfizer
mba 599- pfizermba 599- pfizer
mba 599- pfizer
 
Nestle India Ltd
Nestle India LtdNestle India Ltd
Nestle India Ltd
 
DR REDDYS LABS PPT
DR REDDYS LABS PPTDR REDDYS LABS PPT
DR REDDYS LABS PPT
 
Sun pharma
Sun pharmaSun pharma
Sun pharma
 
Dabur
DaburDabur
Dabur
 
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
FULL DETAIL OF SUN PHARMA & PHARMACEUTICAL INDUSTRY 2015
 
Pfizer company analysis
Pfizer company analysisPfizer company analysis
Pfizer company analysis
 
Pharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysisPharmaceutical industry pestel analysis
Pharmaceutical industry pestel analysis
 
Nestle india
Nestle india Nestle india
Nestle india
 
Pfizer
PfizerPfizer
Pfizer
 
Novartis AG: Science-Based Business
Novartis AG: Science-Based BusinessNovartis AG: Science-Based Business
Novartis AG: Science-Based Business
 
Case Study on Johnson & Johnson
Case Study on Johnson & JohnsonCase Study on Johnson & Johnson
Case Study on Johnson & Johnson
 
Strategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical IndustryStrategic Management presentation for a Pharmaceutical Industry
Strategic Management presentation for a Pharmaceutical Industry
 
Pfizer to Acquire Wyeth
Pfizer to Acquire WyethPfizer to Acquire Wyeth
Pfizer to Acquire Wyeth
 
Novartis - Strategy Memo
Novartis - Strategy MemoNovartis - Strategy Memo
Novartis - Strategy Memo
 
Sun pharma acquires ranbaxy
Sun pharma acquires ranbaxySun pharma acquires ranbaxy
Sun pharma acquires ranbaxy
 
Novartis
NovartisNovartis
Novartis
 
Presentation on cipla project
Presentation on cipla projectPresentation on cipla project
Presentation on cipla project
 

Similar to Financial analysis of novartis pharmaceuticals

Business analysis ppt babasab patil
Business analysis ppt babasab patil Business analysis ppt babasab patil
Business analysis ppt babasab patil Babasab Patil
 
Business analysis ppt
Business analysis ppt Business analysis ppt
Business analysis ppt Babasab Patil
 
Chapter 05(a) financial analysis-ratio and other analysis
Chapter 05(a) financial analysis-ratio and other analysisChapter 05(a) financial analysis-ratio and other analysis
Chapter 05(a) financial analysis-ratio and other analysisAl Sabbir
 
Solvency And Asset Recommendations 2011
Solvency And Asset Recommendations 2011Solvency And Asset Recommendations 2011
Solvency And Asset Recommendations 2011mrittmayer
 
Fundamentals of Financial Ratio Analysis
Fundamentals of Financial Ratio AnalysisFundamentals of Financial Ratio Analysis
Fundamentals of Financial Ratio AnalysisB.V. Raghavendra
 
Financial ratios and their use in understanding Financial Statements
Financial ratios and their use in understanding Financial StatementsFinancial ratios and their use in understanding Financial Statements
Financial ratios and their use in understanding Financial StatementsPranav Dedhia
 
Income StatementBalance SheetCash Flow Statement
Income StatementBalance SheetCash Flow StatementIncome StatementBalance SheetCash Flow Statement
Income StatementBalance SheetCash Flow Statementmanijutt
 
Chapter 6_Interpretation of Financial Statement
Chapter 6_Interpretation of Financial StatementChapter 6_Interpretation of Financial Statement
Chapter 6_Interpretation of Financial StatementPresana1
 
Ratio Analysis Ppt
Ratio Analysis PptRatio Analysis Ppt
Ratio Analysis PptMobasher Ali
 
Financial Report and Ratio Analysis of Square Pharmaceuticals Limited
Financial Report and Ratio Analysis of Square Pharmaceuticals LimitedFinancial Report and Ratio Analysis of Square Pharmaceuticals Limited
Financial Report and Ratio Analysis of Square Pharmaceuticals LimitedMD TOWFIQUR RAHMAN
 
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...Sheeraz Khan
 
Financial Ratio analysis asian paints
 Financial Ratio analysis   asian paints Financial Ratio analysis   asian paints
Financial Ratio analysis asian paintsTushar Sadhye
 
Ratio Analysis of Apex Adelchi Footwear Ltd
Ratio Analysis of Apex Adelchi Footwear LtdRatio Analysis of Apex Adelchi Footwear Ltd
Ratio Analysis of Apex Adelchi Footwear LtdMoin Sarker
 
Ratio AnalysisFinancial ratios can be used to examine various as.docx
Ratio AnalysisFinancial ratios can be used to examine various as.docxRatio AnalysisFinancial ratios can be used to examine various as.docx
Ratio AnalysisFinancial ratios can be used to examine various as.docxcatheryncouper
 
Ratio analysis
Ratio analysisRatio analysis
Ratio analysisAhmad Awan
 
Ratio analysis of square pharma
Ratio analysis of square pharmaRatio analysis of square pharma
Ratio analysis of square pharmaEnamul Islam
 

Similar to Financial analysis of novartis pharmaceuticals (20)

Business analysis ppt babasab patil
Business analysis ppt babasab patil Business analysis ppt babasab patil
Business analysis ppt babasab patil
 
Business analysis ppt
Business analysis ppt Business analysis ppt
Business analysis ppt
 
Chapter 05(a) financial analysis-ratio and other analysis
Chapter 05(a) financial analysis-ratio and other analysisChapter 05(a) financial analysis-ratio and other analysis
Chapter 05(a) financial analysis-ratio and other analysis
 
Solvency And Asset Recommendations 2011
Solvency And Asset Recommendations 2011Solvency And Asset Recommendations 2011
Solvency And Asset Recommendations 2011
 
Fundamentals of Financial Ratio Analysis
Fundamentals of Financial Ratio AnalysisFundamentals of Financial Ratio Analysis
Fundamentals of Financial Ratio Analysis
 
Afs 2 Ratios
Afs 2 RatiosAfs 2 Ratios
Afs 2 Ratios
 
Financial ratios and their use in understanding Financial Statements
Financial ratios and their use in understanding Financial StatementsFinancial ratios and their use in understanding Financial Statements
Financial ratios and their use in understanding Financial Statements
 
Income StatementBalance SheetCash Flow Statement
Income StatementBalance SheetCash Flow StatementIncome StatementBalance SheetCash Flow Statement
Income StatementBalance SheetCash Flow Statement
 
Chapter 6_Interpretation of Financial Statement
Chapter 6_Interpretation of Financial StatementChapter 6_Interpretation of Financial Statement
Chapter 6_Interpretation of Financial Statement
 
Ratio Analysis Ppt
Ratio Analysis PptRatio Analysis Ppt
Ratio Analysis Ppt
 
Financial Report and Ratio Analysis of Square Pharmaceuticals Limited
Financial Report and Ratio Analysis of Square Pharmaceuticals LimitedFinancial Report and Ratio Analysis of Square Pharmaceuticals Limited
Financial Report and Ratio Analysis of Square Pharmaceuticals Limited
 
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...
Comperative analysis of food indusrty(nestle, shezan int, engro food ltd and ...
 
Financial Ratio analysis asian paints
 Financial Ratio analysis   asian paints Financial Ratio analysis   asian paints
Financial Ratio analysis asian paints
 
Ratio Analysis of Apex Adelchi Footwear Ltd
Ratio Analysis of Apex Adelchi Footwear LtdRatio Analysis of Apex Adelchi Footwear Ltd
Ratio Analysis of Apex Adelchi Footwear Ltd
 
Ratio analysis
Ratio analysisRatio analysis
Ratio analysis
 
corporate finance market ratio
corporate finance market ratiocorporate finance market ratio
corporate finance market ratio
 
Ratio AnalysisFinancial ratios can be used to examine various as.docx
Ratio AnalysisFinancial ratios can be used to examine various as.docxRatio AnalysisFinancial ratios can be used to examine various as.docx
Ratio AnalysisFinancial ratios can be used to examine various as.docx
 
Ratio analysis
Ratio analysisRatio analysis
Ratio analysis
 
Ratio analysis of square pharma
Ratio analysis of square pharmaRatio analysis of square pharma
Ratio analysis of square pharma
 
Finance Int 2
Finance Int 2Finance Int 2
Finance Int 2
 

Financial analysis of novartis pharmaceuticals

  • 1. PRESENTED BY:- YASHICA JAIN(A008) SHAGUN AGRAWAL(A001) FINANCIAL ANALYSIS OF NOVARTIS PHARMACEUTICALS.
  • 2. Discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. NOVARTIS
  • 3. COMPANY PROFILE and HISTORY Novartis was created in 1996 through the merger of Ciba- Geigy and Sandoz, two companies with a rich and diverse corporate history. Headquartered in Basel, Switzerland Novartis has been in India since 1947. The Group operates in India through four entities namely Novartis India Limited, Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron-Behring Vaccine Private Limited.
  • 4. In India Novartis have a presence in pharmaceuticals, generics Vaccines, OTC (over-the-counter medicines), eye care and Animal Health. Novartis is among top 20 best performing companies worldwide in carbon emissions from 2005 to 2012 out of 100 companies analyzed, Novartis ranked 18th across all industries, 4th in the healthcare sector and 1st in Switzerland. Continued…
  • 5. PRODUCT PROFILE Novartis is the only company with leading positions in each of these key areas:- 1) Pharmaceuticals: innovative patent-protected medicines 2) Alcon: global leader in eye care with surgical, ophthalmology and consumer products 3) Sandoz: affordable, high-quality generic medicines and biosimilars 4) Consumer Health: self-medication products and treatments for animals 5) Vaccines and Diagnostics: vaccines and diagnostic tools to protect against life-threatening diseases
  • 6. SWOT Analysis SWOT Analysis Strength 1.Has a global reach in over 140 countries 2.Core businesses in pharmaceuticals, vaccines, consumer health, generics and animal health Weakness 1. Controversies regarding their advertising of certain products affected brand image Opportunity 1. Broad-based medical innovation, in technologies and businesses across the spectrum of health care 2. Venture into health needs in under-developed and poor countries Threats 1. Competition from peers
  • 7. Financial and Ratio Analysis Financial Analysis is the process of determining the operating & financial characteristics of a firm from accounting data & financial statement. The goal of such analysis is to determine efficiency & performance of the firm management. Financial analysis is undertaken to fulfil the following objectives.:- such as,  To estimate the earning capacity  To know the financial position and financial performance of the firm  To determine the long terms liquidity of the funds as well as solvency  To decide about the future prospective of the firm
  • 8. Financial Ratio analysis:-  A ratio may be defined as a fixed relationship in degree or number between two numbers.  The ratio analysis is one of the most powerful tools of financial analysis. It is use as a device to analysis and interprets the financial health of enterprise.  Ratio analysis is very helpful in financial forecasting. Ratio relating to the past sales, profits & financial position from the basis for setting future trends.
  • 9. Types of Financial Ratios:- Liquidity Ratio Current ratio Liquid ratio Leverage Ratio Debt equity Total Assets Proprietary Capital Interest Ratio to Debt Ratio Gearing Coverage Turnover Ratio Stock Debtors Creditors Fixed assets working capital Turnover turnover turnover turnover turnover Profitability Ratio Gross Operating Net profit Profits Ratio Ratio Profitability Ratio based on investment Return on Return on Return on equity Earning Per Capital Shareholder fund shareholder fund Share Employed
  • 10. Total Share Capital 15.98 15.98 Equity Share Capital 15.98 15.98 Share Application Money 0 0 Preference Share Capital 0 0 Reserves 801.89 687.01 Revaluation Reserves 0 0 Networth 817.87 702.99 Secured Loans 0 0 Unsecured Loans 0.14 0.2 Total Debt 0.14 0.2 Total Liabilities 818.01 703.19 Mar '12 Mar '11 12 mths 12 mths Application Of Funds Gross Block 23.37 24.15 Less: Accum. Depreciation 13.26 16.2 Net Block 10.11 7.95 Capital Work in Progress 0.1 0.73 Investments 0.03 0.04 Inventories 79.01 53.61 Sundry Debtors 69.95 60.38 Cash and Bank Balance 5.22 6.15 Total Current Assets 154.18 120.14 Loans and Advances 1,551.62 672.89 Fixed Deposits 80.06 82.31 Total CA, Loans & Advances 1,785.86 875.34 Deffered Credit 0 0 Current Liabilities 142.9 114.46 Provisions 835.19 66.43 Total CL & Provisions 978.09 180.89 Net Current Assets 807.77 694.45 Miscellaneous Expenses 0 0 Total Assets 818.01 703.17
  • 11. Profit and Loss Account of Novartis india:- 31 march 2013 31 march 2012 Revenue:- Revenue from Operations (Gross) 9,065.0 8,468.0 Less: Excise Duty 31.4 25.1 Revenue from Operations (Net) 9,033.6 8,442.9 Other Income 831.9 840.1 Total Revenue 9,865.5 9,283.0 Expenses:- Cost of Materials Consumed 403.6 313.9 Purchases of Stock-in-Trade 3,579.3 3,023.8 Changes in Inventories of Finished Goods and Stock-in-Trade (266.4) (222.9) Employee Benefits Expense 1,623.0 1,376.8 Finance Costs 2.2 5.4 Depreciation Expense 35.9 26.7 Other Expenses 2,793.7 2,512.4 Total Expenses 8,171.3 7,036.1 Profit before Tax 1,694.2 2,246.9 Tax Expense For the year Current Tax 570.0 745.0 Deferred Tax 10.5 (15.0) 580.5 730.0 For earlier years Current Tax (Net) (73.7) (3.3) Fringe Benefits Tax (9.9) — 496.9 726.7 Profit for the year 1,197.3 1,520.2
  • 12. Liquidity Ratio Liquidity ratios are generally based on the relationship between current assets and current liabilities . Liquidity ratio refers to the ability of the firm to meet its short term obligations. 1.Current ratio:- this is used to evaluate short term financial position of the business concern. It compares the current assets and current liabilities of the firm. Current ratio = current assets Current liabilities 2012 2011 1785.86/978.09=1.9 i. e. 1.9:1 875.34/180.89=4.8 i.e. 4.8:1 Interpretation:- Ideal current ratio should be 2:1. So, we can say that the company’s financial position is satisfactory in year 2011 and not satisfactory in year 2012
  • 13. Liquid Ratio: -It is very useful in measuring liquidity position of a firm. It measures the firm’s capacity to pay off current obligations. It is used as complimentary ratio to the current ratio. Quick ratio = liquid assets Current liabilities. 2012 2011 1706.85/978.09=1.8 i. e. 1.8:1 821.73/180.89=4.5 i. e. 4.5:1 Interpretation:- Liquid ratio of 1:1 is considered satisfactory. If quick assets are equal to current liabilities, then the concern may be able to meet its short term obligations. Here in both the years liquid asset is greater than the current liabilities, hence the company is much liquid in meeting its short term obligations during both the years.
  • 14. Leverage ratios Leverage ratios analyze the long term solvency that help us judge the ability of a firm to pay the interest regularly 1.Debt equity ratio: shows a relationship between long term debt and shareholder’s fund. This ratio indicates the relation between outsider’s fund and shareholder’s fund. Also called external internal equity ratio Debt equity ratio= debt or long term debt Equity shareholder’s fund . 2012 2011 0.14/817.87=0.00017 0.2/702.99=0.00028 Interpretation:- A ratio of 1:1 is usually considered to be satisfactory. This ratio is calculated to know about the organization’s repayment capacity of long term debts. Here the ratio obtained for both the years is satisfactory.
  • 15. 2.Proprietary ratio: this establishes the relationship between shareholder’s funds to assets of the firm. It is important for determining long term solvency of the firm. Also known as equity ratio or net worth to total assets ratio. Proprietary ratio= Equity Total assets 2012 2011 817.87/818.01=0.99 702.99/703.17=0.99 Interpretation: Higher the ratio, dependency on external sources and loans for working capital will be less and financial condition of the organization will be sound. Here in both the years the ratio is same i. e. o.99 or 99% and very much sound as it is much higher.
  • 16. Turnover ratios They indicate the rapidity with which the resources available to the concern are being used to produce sales. In other words, they measure the efficiency and rapidity of resources of the company 1. Stock turnover Ratio:- inventory ratio. This ratio indicates relationship between cost of goods sold during the year and average stock kept during that year. Stock turnover ratio= cost of goods sold Average stock 2012 2011 843.61/66.31=12.72 742.71/52.49=14.14 Interpretation:- This ratio indicates whether stock has been efficiently used or not ,the number of times the stock is turned into sales during the year. The higher the ratio, the better it is, since it indicates that stock is selling quickly. STR is much higher in year 2011 compared to 2012, hence in 2011 the company's stock has been turned into sales efficiently.
  • 17. 2. Fixed assets turnover ratio: This ratio indicates relationship between costs of goods sold and fixed assets during a year. Fixed assets turnover ratio= cost of goods sold Net fixed assets . 2012 2011 845.61/154.18=5.47 742.71/120.14=6.18 Interpretation:- This ratio reveals how efficiently the fixed assets are being utilized. If there is increase in ratio, it indicates that there is better utilization of fixed assets , here in year 2011 the fixed assets have been utilized efficiently compared to year 2012.
  • 18. 3. Working capital turnover ratio: This ratio indicates relationship between sales and working capital. Working capital turnover ratio = cost of goods sold or sales Working capital 2012 2011 845.61/807.77=1.04 742.71/694.45=1.06 Interpretation:- This ratio reveals how efficiently working capital has been utilized in making sales. A high working turnover ratio shows efficient use of working capital. Here we find that working capital of Novartis pharmaceuticals in year 2011 was efficiently utilized to make sales.
  • 19. CONCLUSION After the overall financial ratio analysis of Novartis pharmaceuticals , it is found that the financial performance and management of company was sound and efficient enough in year 2011 as compared to 2012,as the company was very much liquid during 2011 , current ratio was satisfactory , stock and working capital was efficiently used.